ProMIS Neurosciences has reported the first human evidence that its [...]

Erasca has reported updated preliminary Phase 1 data for its [...]

Tenpoint Therapeutics has submitted a Marketing Authorization Application (MAA) to [...]

Q32 Bio has reported positive 36-week Phase 2 data showing [...]

New Phase 1 data show Vandria’s VNA-318 reaches the human [...]

Poolbeg Pharma has dosed the first patient in a clinical [...]

En Carta Diagnostics has raised €5 million to support regulatory [...]

Theranica’s Nerivio wearable migraine therapy is now covered by health [...]

A Phase 1/1b clinical trial has begun in Australia to [...]

Quest Diagnostics has integrated its Haystack MRD test and comprehensive [...]